Published on

A Shared Journey

Pregnancy is often a transformative time when many women embrace new habits to ensure their baby’s health. However, for women struggling with substance use, it can also be a period fraught with challenges. Every year in the U.S., hundreds of thousands of babies are exposed to tobacco, alcohol, or other substances in utero, leading to significant public health concerns. This article delves into the scope of perinatal substance use, its impacts, and emerging strategies to support mothers and their newborns.

The Prevalence of Perinatal Substance Use

The numbers paint a sobering picture. According to the National Survey on Drug Use and Health, 5.9% of pregnant women report using illicit drugs, 8.5% consume alcohol, and 15.9% smoke cigarettes . This translates to over:

  • 380,000 infants exposed to illicit substances,
  • 550,000 exposed to alcohol, and
  • 1 million exposed to tobacco annually. Polysubstance use, the concurrent use of multiple substances, is particularly concerning and is as high as 50% in some studies. Such patterns complicate efforts to isolate the effects of individual substances and increase the risk of adverse outcomes.

The Impact of Substance Use on Maternal and Infant Health

Substance use during pregnancy can lead to numerous complications, depending on the type of substance, the timing of exposure, and the frequency of use. Some well-documented outcomes include:

Tobacco: A Persistent Problem

Smoking is the most common substance use during pregnancy. Nearly half of smokers quit during pregnancy, particularly those with higher education levels, yet up to 80% relapse within the first year postpartum. The impacts of smoking during pregnancy include:

  • Low birth weight (increased risk with continued smoking beyond the fifth month of pregnancy),
  • Placental abruption, a condition where the placenta detaches from the uterus prematurely,
  • Increased infant mortality rates, and
  • Long-term issues such as increased likelihood of smoking in adolescence among exposed children.
Alcohol: More Than a Glass of Wine

Alcohol consumption during pregnancy is linked to fetal alcohol spectrum disorders (FASD), which include a range of physical, behavioral, and cognitive challenges. Studies have shown:

  • 96% of women with heavy drinking habits reduce consumption during pregnancy, though relapse rates remain significant postpartum.
  • Timing matters: first-trimester exposure is associated with birth defects like oral clefts, while later exposure impacts neurodevelopment .
Cannabis: A Growing Concern

Cannabis is the most frequently used illicit drug during pregnancy, with prevalence estimates ranging from 10% to 43% depending on demographics. Many women perceive it as harmless, but its use has been linked to:

  • Low birth weight (1.7 times more likely among cannabis users),
  • Preterm labor (1.5 times more likely), and

Long-term cognitive and behavioral issues in children.

Opioids: A Rising Epidemic

The opioid crisis has dramatically increased perinatal exposure to drugs like heroin and prescription opioids. Between 2000 and 2009, the incidence of opioid use during pregnancy increased from 1.19 to 5.77 per 1,000 live births, with neonatal abstinence syndrome (NAS) following a similar trajectory . NAS symptoms include:

  • Increased irritability and feeding difficulties,
  • Respiratory distress, and
  • Prolonged hospital stays.

The Road to Recovery: Treatment Options and Success Stories

Behavioral and Psychosocial Interventions

Contingency management (CM) is emerging as one of the most effective approaches for treating perinatal substance use. For instance:

  • In smoking cessation programs, CM doubled abstinence rates at delivery compared to standard interventions.
  • Financial incentives tied to clean urine screens have shown promise in reducing use of substances like cocaine and methamphetamines .
Medications for Treatment

Methadone maintenance therapy remains the standard of care for opioid use disorder during pregnancy, reducing risks of relapse and improving neonatal outcomes.

Buprenorphine, an alternative to methadone, is associated with shorter NAS treatment durations and hospital stays for newborns.

  • Methadone maintenance therapy remains the standard of care for opioid use disorder during pregnancy, reducing risks of relapse and improving neonatal outcomes.
  • Buprenorphine, an alternative to methadone, is associated with shorter NAS treatment durations and hospital stays for newborns.

However, pharmacological treatments for tobacco and other substances are still under investigation. Nicotine replacement therapy, for example, has demonstrated limited efficacy during pregnancy.

Leveraging Technology

Emerging mobile interventions show promise in preventing postpartum relapse. These apps target automatic cues that trigger substance use, offering accessible support during the critical postpartum period.

  • ethadone maintenance therapy remains the standard of care for opioid use disorder during pregnancy, reducing risks of relapse and improving neonatal outcomes.
  • Buprenorphine, an alternative to methadone, is associated with shorter NAS treatment durations and hospital stays for newborns.

Bridging Gaps in Care

While treatment options have advanced, many barriers remain. Pregnant women with substance use disorders often face stigma, lack of access to prenatal care, and co-occurring mental health challenges. Addressing these issues requires a multi-faceted approach:

  • Screening and Education: Routine screenings during prenatal visits can identify substance use early and connect women to care.
  • Community Support: Programs that integrate counseling with social services can address underlying factors like poverty and domestic violence.
  • Policy Changes: Expanding Medicaid coverage for substance use treatment during and after pregnancy can reduce financial barriers.

A Hopeful Future

Substance use during pregnancy presents significant challenges, but it’s also a time when women are uniquely motivated to make positive changes. By building on this motivation and expanding access to evidence-based interventions, we can improve outcomes for mothers and their babies.

If you or someone you know is facing substance use during pregnancy, reach out to healthcare providers or Psychiatrists. Help is available, and every step taken is a step toward a brighter future.

All articles